tradingkey.logo

Seer Inc

SEER
查看詳細走勢圖
1.790USD
-0.030-1.65%
收盤 12/19, 16:00美東報價延遲15分鐘
99.86M總市值
虧損本益比TTM

Seer Inc

1.790
-0.030-1.65%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.65%

5天

+1.70%

1月

-10.50%

6月

-9.60%

今年開始到現在

-22.51%

1年

-22.84%

查看詳細走勢圖

TradingKey Seer Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Seer Inc當前公司基本面數據相對非常健康,增長潛力穩定。當前估值合理,在辦公設備行業排名6/7位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價3.00。中期看,股價處於下降通道。近一個月,市場表現較差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Seer Inc評分

相關信息

行業排名
6 / 7
全市場排名
270 / 4582
所屬行業
辦公設備

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 1 分析師
買入
評級
3.000
目標均價
+52.28%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Seer Inc亮點

亮點風險
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
業績增長期
公司處於發展階段,最新年度總收入14.17M美元
估值合理
公司最新PB估值0.37,處於3年歷史合理位
機構減倉
最新機構持股32.64M股,環比減少19.98%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉2.22M股

Seer Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Seer Inc簡介

Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
公司代碼SEER
公司Seer Inc
CEOFarokhzad (Omid C)
網址https://seer.bio/

常見問題

Seer Inc(SEER)的當前股價是多少?

Seer Inc(SEER)的當前股價是 1.790。

Seer Inc 的股票代碼是什麼?

Seer Inc的股票代碼是SEER。

Seer Inc股票的52週最高點是多少?

Seer Inc股票的52週最高點是2.510。

Seer Inc股票的52週最低點是多少?

Seer Inc股票的52週最低點是1.620。

Seer Inc的市值是多少?

Seer Inc的市值是99.86M。

Seer Inc的淨利潤是多少?

Seer Inc的淨利潤為-86.60M。

現在Seer Inc(SEER)的股票是買入、持有還是賣出?

根據分析師評級,Seer Inc(SEER)的總體評級為買入,目標價格為3.000。

Seer Inc(SEER)股票的每股收益(EPS TTM)是多少

Seer Inc(SEER)股票的每股收益(EPS TTM)是-1.361。
KeyAI